Metraipolis › archive › dc_20e2a1436656
Real-world outcomes of pembrolizumab in advanced anal cancer: a nationwide Danish anal Cancer Group report — Europe PMC PMID:42109075
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42109075
- DOI
- 10.2340/1651-226x.2026.44690
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T11:37:56.467Z
- SHA-256 of the archived text
6ba43c52770fde98ca2de1af92b589f13ba91ea19d899e4b6477da2f173ce03d- Stable URL of this page
https://metraipolis.com/documento/dc_20e2a1436656
How to cite
Real-world outcomes of pembrolizumab in advanced anal cancer: a nationwide Danish anal Cancer Group report — Europe PMC PMID:42109075 — Europe PMC (en), https://europepmc.org/article/MED/42109075 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_20e2a1436656 (Metraipolis archive dc_20e2a1436656, sha256 6ba43c52770fde98ca2de1af92b589f13ba91ea19d899e4b6477da2f173ce03d)
BibTeX
@misc{dc20e2a1436656,
title = {Real-world outcomes of pembrolizumab in advanced anal cancer: a nationwide Danish anal Cancer Group report — Europe PMC PMID:42109075},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42109075},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_20e2a1436656; sha256 6ba43c52770fde98ca2de1af92b589f13ba91ea19d899e4b6477da2f173ce03d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42109075. Agents can read the archived copy with the MCP tool read_document.